P869: UPDATED RESULTS OF A PHASE I, OPEN-LABEL STUDY OF BCMA/CD19 DUAL-TARGETING FASTCAR-T GC012F FOR PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)
Authors:
Open Access
- 8 August 2023
- journal article
- abstracts
- Published by Wiley in HemaSphere
- Vol. 7 (S3) , e84060bf